Tech Company Financing Transactions
Castle Biosciences Funding Round
Castle Biosciences, based in Phoenix, secured $20 million from Oxford Finance and Silicon Valley Bank.
Transaction Overview
Company Name
Announced On
5/10/2017
Transaction Type
Debt
Amount
$20,000,000
Round
Undisclosed
Investors
Oxford Finance (Christopher Herr)
Silicon Valley Bank (Anthony Flores)
Proceeds Purpose
Proceeds from the credit facility are being used to provide additional working capital as Castle accelerates marketing support and new product development to further help patients and their physicians make the best possible treatment and follow-up care decisions based on the molecular signatures of their tumors.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
3737 N. 7th St. 160
Phoenix, AZ 85014
USA
Phoenix, AZ 85014
USA
Phone
Website
Email Address
Overview
Castle Biosciences (Nasdaq: CSTL) offers diagnostic tests that provide actionable, tumor-specific information for improved treatment decisions and patient outcomes.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Derek Maetzold
Chief Financial Officer
Frank Stokes
Chief Medical Officer
Federico Monzon
Chief Operating Officer
Bernhard Spiess
VP - Operations
Kristen Oelschlager
VP - R & D
Robert Cook
VP - Sales
Toby Juvenal
Browse more venture capital transactions:
Prev: 5/10/2017: Signal Sciences venture capital transaction
Next: 5/10/2017: Cover Technologies venture capital transaction
Share this article
Where The Data Comes From
We report on all VC transactions involving tech companies. All VC database entries on this site are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs